Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy

1. Sharma, A.
2. Muresanu, D.F.
3. Patnaik, R.
4. Menon, P.K.
5. Tian, Z.R.
6. Sahib, S.
7. Castellani, R.J.
8. Nozari, A.
9. Lafuente, J.V.
10. Buzoianu, A.D.
11. Skaper, S.D.
12. Bryukhovetskiy, I.
13. Manzhulo, I.
14. Wiklund, L.
15. Sharma, H.S.